Finance

Beta
Lists
214150:KOSDAQ
Classys Inc
â‚©42,000.00
-1.98%
(-850.00) 1D
Jun 8, 3:30:15 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 214150...
Open
â‚©40,800
High
â‚©43,100
Low
â‚©40,150
Mkt. cap
2.74T
Avg. vol.
276.34K
Volume
329.43K
Dividend
2.38%
Quarterly dividend
â‚©250
Ex-dividend date
Dec 29, 2025
P/E ratio
20.32
52-wk high
â‚©77,600
52-wk low
â‚©40,150
EPS
â‚©2,067
Shares outstanding
65.24M
No. of employees
394
Open
â‚©40,800
High
â‚©43,100
Low
â‚©40,150
Mkt. cap
2.74T
Avg. vol.
276.34K
Volume
329.43K
Dividend
2.38%
Quarterly dividend
â‚©250
Ex-dividend date
Dec 29, 2025
P/E ratio
20.32
52-wk high
â‚©77,600
52-wk low
â‚©40,150
EPS
â‚©2,067
Shares outstanding
65.24M
No. of employees
394
News stories
From sources across the web
Profile
Classys Inc. is a South Korean medical device company headquartered in Seoul, South Korea. It was founded in 2007 by dermatologist Jung Sung-jae and specializes in non-invasive skin care and aesthetic treatment technologies. As of 2025, Classys exports its devices to over 60 countries. Wikipedia
About Classys Inc
CEOSeunghan Baek
Employees394
Founded2007
Headquarters-
SectorMedical device
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
83.28B
83.00B
93.43B
87.18B
Cost of goods sold
19.27B
19.27B
21.40B
22.13B
Cost of revenue
19.27B
19.27B
21.40B
22.13B
Research and development expenses
4.24B
4.36B
4.69B
4.71B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.07B
18.97B
13.37B
20.37B
Operating expense
21.01B
26.11B
20.83B
27.85B
Total operating expenses
40.27B
45.38B
42.24B
49.98B
Operating income
43.01B
37.62B
51.19B
37.20B
Other non operating income
-824.82M
-62.40M
-1.85B
-198.78M
EBT including unusual items
31.91B
42.84B
54.33B
44.85B
EBT excluding unusual items
32.17B
42.84B
52.80B
44.83B
Income tax expense
5.44B
9.73B
11.66B
11.69B
Effective tax rate
17.04%
22.72%
21.47%
26.07%
Other operating expenses
-
-
-
-
Net income
26.47B
33.01B
42.64B
33.62B
Net profit margin
31.78%
39.77%
45.64%
38.56%
Earnings per share
401.00
502.00
650.00
514.00
Interest and investment income
1.21B
1.28B
1.54B
2.05B
Interest expense
-574.95M
-553.63M
-608.79M
-1.55B
Net interest expenses
636.52M
730.15M
930.88M
494.71M
Depreciation and amortization charges
749.74M
779.83M
762.86M
759.06M
EBITDA
46.65B
41.34B
54.92B
41.05B
Gain or loss from assets sale
258.62M
-990.03K
746.13M
-13.43M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more